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Abstract
Background: Atrazine (2-chloro-4-ethytlamino-6-isopropylamine-1,3,5-triazine; ATR), is the most commonly applied
broad-spectrum herbicide in the world. Unintentional overspray of ATR poses an immune function health hazard.
The biomolecular mechanisms responsible for ATR-induced immunotoxicity, however, are little understood. This
study presents on our investigation into the apoptosis of splenocytes in mice exposed to ATR as we explore
possible immunotoxic mechanisms.
Methods: Oral doses of ATR were administered to BALB/C mice for 21 days. The histopathology, lymphocyte
apoptosis and the expression of apoptosis-related proteins from the Fas/Fas ligand (FasL) apoptotic pathway were
examined from spleen samples.
Results: Mice administered ATR exhibited a significant decrease in spleen and thymus weight. Electron microscope
histology of ultrathin sections of spleen revealed degenerative micromorphology indicative of apoptosis of
splenocytes. Flow cytometry revealed that the percentage of apoptotic lymphocytes increased in a dose-
dependent manner after ATR treatment. Western blots identified increased expression of Fas, FasL and active
caspase-3 proteins in the treatment groups.
Conclusions: ATR is capable of inducing splenocytic apoptosis mediated by the Fas/FasL pathway in mice, which
could be the potential mechanism underlying the immunotoxicity of ATR.
Background
Atrazine (2-chloro-4-ethytlamino-6-isopropylamine-
1,3,5-triazine; ATR) is the most extensively used broad-
spectrum herbicide in the world. Scientists from many
countries are increasingly concerned and interested in
ATR due to its adverse environmental effects. Residues
of ATR, its primary metabolite, deethylatrazine, and
other derivatives of the parent compound can leach
from soils and persist in ground and surface water for
several years [1,2]. It is frequently detected as an envir-
onmental pollutant at concentrations exceeding the
maximum containment level as set by the US Environ-
mental Protection Agency (EPA) [3]. Occupational
exposure of farmers and other agricultural workers to
high concentrations of ATR is of particular concern.
Levels of ATR exposure can be detected in the saliva
and urine of these workers after spraying. It is not only
the direct ATR applicators at risk, but also their families
through detectable levels in body fluids. Considerably
higher amounts of ATR and its metabolites are found in
the urine in populations living within proximity of farms
that use this herbicide [4]. ATR has also been found in
the urine of children of non-agricultural families,
demonstrating non-occupational exposures [5].
Many toxicological studies of ATR focus primarily on
the effects of ATR on the endocrine and reproductive
systems. ATR affects levels of steroid hormones and
interferes with the critical pathways for sex-specific phy-
siological and behavioral development. This includes
activation of the hypothalamic-pituitary-adrenal axis and
disruption of related androgen-mediated processes,
which results in demasculinization and feminization of
male amphibians and rodents [6-9]. Prenatal and lacta-
tional ATR exposure affects the health and development
of the male offspring in rats [10-12]. Further studies
show that ATR increases aromatase activity by binding
to and inhibiting phosphodiesterase, which elevates
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duction [13-15]. Exposure to ATR results in dopaminer-
gic neurotoxicity by disrupting vesicular storage and/or
cellular uptake of striatal dopamine (DA), as well as tar-
geting the nigrostriatal dopaminergic pathway, which
decreases intracellular DA concentrations [16-20]. There
is growing evidence suggesting that ATR can induce
oxidative stress and DNA damage [21-23].
While there are numerous studies regarding the detri-
mental effects of ATR on endocrine and reproductive
development, studies assessing the immunotoxic poten-
tial of ATR are scarce. A single oral dose of ATR causes
transient suppression of IgM production and T cell pro-
liferation in adult mice [24]. Brodkin et al. [25] sug-
gested that exposure to ATR affects the innate immune
response in frogs. Oral administration of ATR for 14
days is immunotoxic in mice, manifesting as an increase
in the number of CD8
+ T cells and an increased cyto-
toxicity of T cells. A decrease of thymus and spleen
weights, and total spleen cell numbers are also observed
in C57BL/6 mice after daily oral treatment for 14 days
at up to 250 mg/kg/day or 500 mg/kg/day [26,27]. Stu-
dies on the immunotoxicity effects of ATR have mainly
been focused on the evaluation of immunity function.
Less attention has been directed toward the mechanisms
by which these functions are modulated.
The active apoptotic pathway in the immune system is
regulated by Fas/Fas ligand (FasL) cytokine death recep-
tors in lymphoid cells [28,29]. The Fas (also known as:
CD95 or Apo-1) receptor protein crosslinks with its
ligand FasL (or CD95L) and leads to the assembly of a
death-inducing signal complex initiating caspase-
mediated apoptosis [30,28]. The Fas receptor and ligand
system is widely distributed in active B and T lympho-
cytes. Binding of FasL to Fas-bearing cells serves impor-
tant immune system functions through activation-
induced cell death; this system is also an effector of
cytotoxic T cell and natural killer cell activities. Follow-
ing infection, many B or T lymphocytes can become
useless or harmful after their receptor genes have been
rearranged. Homeostatic immunity is regulated by FasL
mediated apoptosis eliminating these antigen-specific
lymphocytes in excess, which regulates a steady-state
supply of lymphocytes in periphery tissues. Immunotoxi-
city leading to the negative modulation via overexpres-
sion of Fas regulatory genes, however, can cause excess
apoptosis of lymphocytes, which suppresses cellular and
humoral immune responses [31,32].
Liu et al. [33] demonstrated ATR induced apoptosis in
fish cells. Singh et al. [21] identified an ATR induced
genotoxic effect, but no study has yet to report on ATR
induced apoptosis in mammals. This study explores the
effects of ATR-induced apoptosis in splenic lymphocytes
on Fas/FasL proteins involved in the apoptotic pathway.
This study provides evidence of a possible mechanism
by which ATR-induced immunotoxicity can occur in a
rodent or, more generally, a mammalian model.
Methods
Chemicals and reagents
Atrazine (CAS Registry Number: 301-49A; 2-chloro-4-
ethylamino-6- isopropylamino-s-triazine, ATR, 98% pur-
ity) was obtained from ChemServices (West Chester,
PA, USA). b Actin rabbit polyclonal antibodies, Fas,
FasL and caspase-3 rabbit monoclonal antibodies, as
well as the alkaline phosphatase-conjugated secondary
antibodies were acquired from Santa Cruz Biotechnol-
ogy (SantaCruz, CA, USA). The annexin-V/propidium
iodide (PI) Kit was purchased from Pharmingen (Becton
Dickinson Company, NJ, USA). ATR solutions (5 mg/
ml, 10 mg/ml and 20 mg/ml) were prepared by dissol-
ving ATR in 3% starch solution. All the solutions were
kept at 4°C for a maximum of 1 week.
Animals and treatment
Male and female BALB/C mice (16-18 g) were pur-
chased from Tumor Hospital of Heilongjiang Province
(Harbin, China). The animals were treated in accordance
to the criteria outlined in the Guide for the Care and
Use of Laboratory Animals prepared by National Insti-
tutes of Health. After acclimatization for 1 week, the
mice were housed in standard polyethylene cages, in
groups of five mice per cage and per sex, with wood
shavings as bedding and given purified water and rodent
chow ad libitum. Animal rooms were maintained at a
12 h light/dark cycle at 22 ± 2°C and 50% ± 15% relative
humidity. Male and female mice were randomly divided
into four groups by body weight (five mice/sex/group).
Animals were treated by a daily gavage of 20 μl/g body
weight at doses of 0 (3% starch solution, vehicle control)
or 100, 200 and 400 mg/kg ATR for 21 consecutive
days.
Body weight and organ weight
Body weight was recorded once a week. Upon being
killed after 21 treatment days, the spleen, thymus, liver
and kidney were removed aseptically and weighed. The
relative weight of the organs of each mouse was calcu-
lated as organ weight (mg)/body weight (g).
Preparation of splenocytes
Splenocytes were harvested as described in Gao et al.
[34]. The spleen was removed at the time of killing and
a single-cell suspension was prepared by forcing spleen
through a 400 μm stainless steel mesh. Erythrocytes
were lysed with hypotonic buffered solution and lym-
phocytes were washed with Hanks’ balanced salt solu-
tion (HBSS) prior to being resuspended in RPMI 1640
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exclusion method using a hemocytometer. Finally, cells
were adjusted into different concentrations with RPMI
1640 medium supplemented with 10% fetal calf serum.
Histopathological examination
Light microscope
After fixation with 10% buffered formalin, the spleen
was dehydrated, processed, and embedded in paraffin.
Serial sections (5 μm) were prepared and stained with
Harris’s hematoxylin and eosin (H&E) for histopatholo-
gical evaluation by light microscope.
Transmission electron microscope
The spleen was cut into 1 mm
3 size cubes and fixed in
1% freshly made paraformaldehyde with 2% glutaralde-
hyde for 24 h. Samples were fixed for 2 h in 1% osmium
tetroxide and dehydrated in graded ethanol and
embedded in araldite. Ultrathin sections were cut and
stained with uranyl acetate and lead citrate, and then
observed with transmission electron microscope (JEM-
101, Jeol Electron Inc., Tokyo, Japan).
Apoptosis assay
Apoptosis was assessed by using annexin-V/PI Kit fol-
lowing manufacturer’si n s t r u c t i o n sa sd e s c r i b e di nG a o
et al. [34]. Briefly, spleen lymphocytes were collected as
above, adjusted to 2×10
6 cells/ml, then treated with a
final concentration of 80 mg/ml RNase I, and stained
with 50 mg/ml PI and 50 mg/ml annexin-V/fluorescein
isothiocyanate (FITC) for 15 min at room temperature
in the dark and analyzed by Flow Cytometry (Becton
Dickinson, Franklin Lakes, NJ, USA) equipped with
Cell-Quest software analysis. A minimum of three inde-
pendent experiments were performed in each assay.
Western blot
Western blot analyses for the expression of Fas, FasL,
active caspase-3 and b actin were performed as described
in Zhang et al. [35]. Spleen was homogenized in ice-cold
50 mM Tris-HCl buffer (pH 7.4) containing 0.25 M
sucrose and a 1% protease inhibitor cocktail. The homo-
genate was centrifuged at 4°C, 10,000 g,f o r1 0m i na n d
the supernatant was collected. Protein concentrations
were determined by the Bradford protein assay. Equal
amounts of protein were resolved by 10% (v/v) sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), followed by electrophoretic transfer to Immobi-
lon-P membranes. Blots were blocked in Tween 20 Tris-
buffered saline containing 3% (w/v) non-fat dry milk for
1 h at room temperature. Membranes were incubated
over night at 4°C with an appropriately diluted primary
antibody and were then incubated with an appropriately
diluted secondary antibody in blotting buffer for 1 h with
agitation at room temperature. Visualization of the pro-
teins was performed by an enhanced chemiluminescence
system (Amersham Biosciences, Piscataway, NJ, USA)
according to manufacturer’sp r o t o c o l .D e n s i t yo fb a n d s
was quantified by densitometry. b Actin was used to nor-
malize the samples.
Statistics
Data were analyzed using SPSS (Chicago, IL, USA) by
one-way analysis of variance (ANOVA) followed by
Dunnett’s multiple comparisons testing to identify sig-
nificant differences between groups. All data were
expressed as mean ± SD. Differences were regarded as
significant at the value of P <0.05.
Results
General state of mice
All animals survived until the end of the study. There
were no overt changes in appearance and/or behavior,
as well as no significant differences in body weight (data
no shown) in the male and female mice following ATR
exposure.
Toxic effect of ATR on the spleen
Mean spleen and thymus weight and their relative
weight decreased in the mice of both sexes in the 200
and 400 mg/kg ATR treatment groups (P <0.05), com-
pared to control group, as shown in Table 1. There
were no significant alteration of weight and relative
weight of liver and kidneys (data no shown).
The histopathological examinations of the spleen
under the light microscope revealed degenerative
changes. Spleens appeared atrophic in the 200 mg/kg
and 400 mg/kg ATR groups, characterized by the efface-
ment of germinal centers, diminution of white pulp, and
Table 1 Summary weights of spleen and thymus in mice
Group Spleen weight (mg) Spleen relative weight (mg/g) Thymus weight (mg) Thymus relative weight (mg/g)
Control group 92.2 ± 2.50 4.02 ± 0.407 46.6 ± 2.46 2.05 ± 0.220
100 mg/kg ATR 92.0 ± 1.92 3.99 ± 0.521 44.7 ± 1.25 1.95 ± 0.395
200 mg/kg ATR 79.4 ± 1.74* 3.44 ± 0.312* 41.7 ± 0.62* 1.83 ± 0.450*
400 mg/kg ATR 71.4 ± 2.01* 3.16 ± 0.372* 40.4 ± 1.32* 1.78 ± 0.254*
Each value represents mean ± SD (n = 10, males and females combined).
*P <0.05 compared to control group.
ATR = atrazine (2-chloro-4-ethytlamino-6-isopropylamine-1,3,5-triazine).
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were observed in the control and 100 mg/kg ATR
groups. Transmission electron microscopy showed wide
karyopyknosis, perinuclear cistern widening, mitochon-
drial degeneration, and formation of apoptotic bodies in
the lymphocytes, all of which were characteristics of
cells undergoing apoptosis. These changes were notable
in the spleen with dosages of 200 mg/kg and 400 mg/kg
ATR groups (Figure 2).
Flow cytometry
Analysis by flow cytometry revealed that the percentage
of apoptotic lymphocytes in the spleen was significantly
increased in 200 mg/kg and 400 mg/kg ATR treatment
groups, which there were statistic difference with the
comparison to the control group (P <0.05). In the 400
mg/kg ATR-treated group, the percentage of apoptotic
lymphocytes increased fourfold compared to the control
group (Figures 3 and 4).
Expression of apoptotic proteins
The western blot showed a dose-dependent increased
expression of Fas, FasL and active caspase-3 proteins in
200 mg/kg and 400 mg/kg ATR-treated groups, com-
pared to control group (Figure 5). The b actin control
remained constant as expected.
Figure 1 Histopathological cross sections showing light microscopy of spleen in mice treated with atrazine (2-chloro-4-ethytlamino-6-
isopropylamine-1,3,5-triazine; ATR) (hematoxylin and eosin (H&E) stain, magnification ×10). (a) Control group. The histological structure is
normal. (b) The 200 mg/kg ATR group. Atrophic and effaced splenic germinal centers, the diminution of white pulp (filled triangles) and
congestion of red pulp (arrow) in the spleen can be seen. (c) The 400 mg/kg ATR group. Effaced splenic germinal centers and the diminution of
white pulp (filled triangles), associated with obvious congestion in red pulp (arrow).
Figure 2 Transmission electron microscope images showing the ultrastructural properties of splenocytes from mice treated with
atrazine (2-chloro-4-ethytlamino-6-isopropylamine-1,3,5-triazine; ATR). (a) Control group. Splenocytes showing normal phenotype
(magnification ×10,000). (b) The 200 mg/kg ATR group. Splenocytes exhibiting chromatin margination and condensation into dense granules or
blocks (filled triangles), as well as mitochondrial vacuolization (arrow) (magnification ×5,000). (c) The 400 mg/kg ATR group. Splenocytes
exhibiting apoptotic morphology including chromatin margination, mitochondrial vacuolization (arrow) and formation of apoptotic bodies (filled
triangles) (magnification ×15,000).
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The immune system is a complex network of interact-
ing regulatory genes, hormones, and cells that has
evolved in multicellular organisms for the purpose of
maintaining a homeostasis against a dynamic battery of
foreign environmental agents and/or pathogens. Envir-
onmental pollutants can interfere with the normal
operation of the immune system leading to a broad
range of disorders, including endocrine dysfunction,
tumorigenesis, increased rates of inflammatory infec-
tious, and autoimmune diseases. Widespread use of the
herbicide ATR increases the chance and rates of expo-
sure to another foreign agent that immune system must
contend with. Immunotoxicity of ATR manifests as a
decrease in immune response capacity, including the
suppression of immune cell function, atrophy of
immune organs [24-26]. This study adds to a growing
list of publications reporting on the adverse physiologi-
cal effects of ATR. Surprisingly, overt changes in
outward appearance or behavior were not observed in
mice administered even the highest ATR dosage. How-
ever, spleen and thymus weights decreased significantly
in a dose-dependent manner, apoptosis of lymphocytes
was recorded in the spleen, and an altered apoptotic
protein pathway occurred in mice administered a range
of ATR dosages.
Experimental dosage amounts given to mice ranged
from 100 mg/kg to 400 mg/kg. These amounts are
based on the concentrations used in previous studies
[26,27] and are higher than might be expected in natural
conditions. However, these amounts ensured the desired
effect for the purposes of this study. In California, the
potential occupational exposure to atrazine was assessed
during mixing, loading and application to field corn and
it was estimated that absorbed daily dosages (ADD) of
ATR for a mixer-loader-tender applicator was 1.8-6.1
μg/kg/day for short-term exposure (15-21 days) [36,37].
The ADD of ATR is expected to be higher in commer-
cial applicators and farmers in developing country due
to inappropriate personal protective equipment and
unintentional overspray. Atrazine is not removed from
the body within 24 h and its metabolites can still be
detected in the urine 48 h after a dose to humans [38].
It is therefore possible that some kinds of effect could
occur after repeated dosing and result from an accumu-
lation of chemical above a critical threshold.
Abnormal weight of the spleen and thymus may be an
important indicator and a simple method to investigate
potential cases of ATR immunotoxicity. The decrease of
immune organ weight may be associated with the inhi-
bition of lymphocytes proliferation and/or the increase
of lymphocyte death in the spleen and thymus [39,40].
Closer examination using microscopy revealed degenera-
tive histopathological alterations, although this study
does not report the functional immunity of the spleen
directly. These results do provide, however, indirect evi-
dence that ATR exposure has an adverse impact on the
functional immunity of the spleen in mice. This
Figure 3 Flow cytometry plots of splenocytes apoptosis. The splenocytes were isolated from mice treated with atrazine (2-chloro-4-
ethytlamino-6-isopropylamine-1,3,5-triazine; ATR) for 21 days. The annexin-V and propidium iodide (PI) fluorescence was measured using flow
cytometer. Results were expressed as dot plots. (a) Control group; (b) 100 mg/kg ATR; (c) 200 mg/kg ATR; (d) 400 mg/kg ATR.
Figure 4 Histogram showing the percentage of splenocytes
exhibiting apoptosis induced by atrazine (2-chloro-4-
ethytlamino-6-isopropylamine-1,3,5-triazine; ATR) in mice (n =
10). With the increasing concentration of ATR, the apoptotic
percentage of splenocytes increased. *P <0.05, compared to control
group.
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the adverse effects of ATR on the immune system
[26,27].
The role of toxin-induced apoptosis has been a major
theme in toxicological evaluation, although the relative
contribution of apoptosis caused by toxins remains
unclear. Studies have shown a cytotoxic effect of ATR
on aquatic organisms and amphibians mediated by indu-
cing apoptosis [33,41]. This is the first study that we are
aware that identifies ATR-induced apoptosis in a rodent.
Splenocytes exhibited the morphological phenotype of
apoptosis after ATR exposure and the percentage of
apoptotic lymphocytes increased in a dose-dependent
manner. Cellular scale ATR-induced apoptosis provides
a reasonable explanation for the noted decrease in
spleen weight and atrophy in the germinal center of the
spleen.
The main aim of this study was to test for possible
immunotoxic mechanisms operating at a subcellular
scale using a western blot analysis focusing on proteins
(Fas, FasL, and caspase-3) that have a central role in the
execution of cellular apoptosis. Our results show ATR
exposure increases Fas and FasL protein expression in
the spleen in dose-dependent manner, which suggests
the following immunotoxic mechanisms take effect. The
spleen is a peripheral lymphoid organ where lympho-
cytes are activated upon being presented with foreign
antigens. Activated lymphocytes are sensitive to signals
that lead to apoptosis [42]. When the peripheral lym-
phocytes are activated following stimulation with a for-
eign antigen, such as ATR, lymphocyte apoptosis
becomes activated. The fine balance between antiapop-
totic and apoptotic genes and/or proteins is altered,
which leads to the activation of caspases through cas-
cade reaction. Among caspases, active caspase-3 is the
key executioner of apoptosis because it is the final effec-
ter enzyme (and also one of the most important) for
shearing chromatins [43]. Our results from western
blotting shows that there is a higher expression of active
caspase-3 in the spleen of mice after ATR exposure.
Consequently, lymphocytes exhibit the morphological
characteristics of cells undergoing apoptosis, such as
karyopyknosis, apoptotic bodies, and so on. Hence, the
immune function of the spleen is impaired by the death
of lymphocytes.
Conclusions
This study provides the first evidence of ATR inducing
apoptosis of lymphocytes in a rodent. This indicates the
existence of a novel cytotoxic mechanism caused by
ATR. Mice administered ATR dosages experience upre-
gulation of Fas/FasL and active caspase-3 proteins. This
suggests an immunotoxicological linkage to one of the
key lymphocyte immunity regulatory systems. However,
many molecular mechanisms involved in this process
still remain unclear. Therefore, further research is
needed to elucidate more fully the mechanisms of the
deleterious effects of ATR on the immune system and
to investigate prolonged exposure under natural field
conditions.
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Figure 5 Western blot gel (a) and histogram (b) showing relative expression of Fas, FasL and active caspase-3 proteins in the spleen.
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Quantification analysis of the western blot. The results were expressed as the ratio of target protein/b actin in each group. *P <0.05, compared
to control group.
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